Answers are grounded in this paper and cite their sources.
In hepatic adenomatosis, a rare entity first described by Flejou et al. (1) in 1985, multiple liver cell adenomas (usually > 10) occur in patients with no prior history of oral contraceptive use, androgenic steroid use, or glycogen storage disease. So far, only 18 cases have been reported, including two cases in patients under 18 years of age (1-12). We report an adolescent with hepatic adenomatosis and briefly review the literature (Table 1). CASE REPORT A 17-year-old white girl was evaluated at a community hospital for complaints of afternoon headaches, which were relieved by acetaminophen, and sharp abdominal pains that occurred monthly, lasted 1-2 days, and resolved spontaneously. She had no history of prior illnesses or oral contraceptive use. A urinalysis showed hematuria and proteinuria, and culture was negative. Abdominal ultrasound showed hydronephrosis of the left kidney, a left ovarian mass, and multiple liver masses. Laparoscopic examination revealed hydronephrosis of the left kidney, normal uterus and fallopian tubes, and a cystic left ovary. No abnormal fluid or tumor implants were noted in the pelvis or peritoneum. The liver appeared markedly enlarged. On the surface of the right lobe was a tumor measuring about 6 cm in diameter. The tumor was yellowish, soft, and appeared to have markedly increased vascularity. A kidney biopsy showed minimal change, and prednisone was administered at a dose of 1 mg/kg/day for management of nephrotic syndrome. She was referred to our center for further evaluation of the liver masses. Physical examination showed that liver was palpable ≈ 14 cm below the right costal margin in the mid-clavicular line, with a total percussable span of 24 cm, and extended 5 cm to the left of the midline. The spleen was not palpable, and there were no signs of portal hypertension or chronic liver disease. Pertinent laboratory tests included the following: hemoglobin 9.8 g/dl (normal, 11.5-15.5), hematocrit 29.4% (normal, 36-47), albumin 4.0 g/dl (normal, 3.5-5.0), total bilirubin 0.4 mg/dl (normal, 0.1-1.2), alanine aminotransferase 41 IU/L (normal, 15-59), gamma glutamyl transpeptidase 432 IU/L (normal, 8-35), alkaline phosphatase 193 IU/L (normal, 150-650), and prothrombin time 12 s (normal, 11.0-13.4). A CT scan without intravenous contrast showed 20 low-density lesions within the liver, each with a dense rim. The density of all lesions enhanced after the infusion of intravenous contrast material. The largest of these lesions measured 6.5 cm in diameter (Fig. 1). The patient underwent a laparotomy for the purpose of an open liver biopsy. Histopathology showed hepatocytes arranged in cords with fatty metamorphosis but no significant nuclear pleomorphism. No normal portal structures—and in particular, no bile ducts—were identified within the tumors. Trichrome stain demonstrated perivenular fibrosis. No areas of hemorrhage or necrosis were seen (Fig. 2). A year later, the patient was clinically unchanged. Repeat CT scan of the liver showed minimal change in the size of the hepatic masses. DISCUSSION Liver cell adenoma (hepatocellular adenoma) is an uncommon liver tumor that is strongly associated with oral contraceptive use (1,2,13). Prior to the advent of oral contraceptive use in 1960, only four cases of hepatic adenomas had been described. When Benz and Bagenstoss reviewed necropsy material at the Mayo Clinic in 1922-51, they identified two patients with hepatic adenomas (14). Edmonson found only two hepatic adenomas among over 50,000 autopsies performed between 1918 and 1954 at Los Angeles County General Hospital (15). Baum et al. first described the association with oral contraceptives in 1973 (16). Although liver cell adenomas are usually solitary, in 21% of cases they are multiple, usually less than three. Because of the association with oral contraceptives, they have a female preponderance, but they have also been reported in patients receiving androgenic steroids and in patients with glycogen storage disease, especially type 1 (17,18). The liver parenchyma outside of the adenomas is usually normal, although both adenomas and focal nodular hyperplasia are rarely encountered in patients receiving oral contraceptives (5). Liver tests are normal in the majority of patients. There are case reports of malignant transformation within a hepatic adenoma, especially when associated with glycogen storage disease or oral contraceptive use (17-19). Adenomas appear to regress after discontinuing oral contraceptives or androgenic steroids (20,21). Hepatic adenomatosis is defined by the presence of numerous (> 10) hepatic cell adenomas in an otherwise normal hepatic parenchyma (1,3). The incidence is equal for men and women, and the disease is not associated with oral contraceptives, androgenic steroids, or glycogen storage disease. Extratumorous hepatic tissue is usually normal, although two patients with focal nodular hyperplasia and granulomatous hepatitis have been reported (5). There have been no reports of malignancy arising from hepatic adenomatosis, but this may reflect the rareness of the syndrome and the lack of long-term follow-up of the reported cases rather than the actual risk for malignant transformation. Clinical symptoms are mild to absent in most patients with hepatic adenomatosis; in most cases, the disorder probably goes unrecognized for many years. This is probably the case in our patient, for example, considering the size of the tumors at the time of diagnosis and their subsequent growth rate. Modest to extreme hepatomegaly can be detected in most patients. Hepatomegaly is sometimes accompanied by dull abdominal pain or a sense of fullness in the right upper quadrant. No reported patient has exhibited clinical evidence of parenchymal insufficiency or portal hypertension. Forty-six percent of the reported cases of hepatic adenomatosis have experienced intratumorous or intraperitoneal bleeding, which is higher than the 25-35% occurrence in patients with hepatic adenomas (1,19). The bleeding is secondary to rupture of the very vascular adenomas either spontaneously or following trivial abdominal trauma (1). Acute epigastric or right upper quadrant abdominal pain can accompany bleeding and may be the first symptom of disease. In one case, pruritis persisted even after excision of the tumors (1). Radiologic imaging is useful in the diagnosis of hepatic adenomatosis. The tumors may be hyperechoic or hypoechoic when imaged by ultrasound (1,4). Hyperechoic tumors are usually fatty. Most lesions are less dense than surrounding parenchyma in CT scans performed without intravenous contrast. A high-density rim may be seen around the low-density lesions, possibly due to compression of the surrounding normal liver parenchyma, and entire nodules may rarely be hyperdense. After infusion of intravenous contrast, there is enhancement of the lesions from center to the periphery related to their increased vascularity. These typical changes were also seen in our case. There has been one case report of intratumoral calcification seen on CT scan, most likely secondary to prior hemorrhage (4). Magnetic resonance imaging (MRI) usually shows the lesions as well defined, relatively homogenous, high-intensity masses (3). Arteriogram shows a hypervascular tumor in the arterial phase, while in the venous phase, intrahepatic veins are displaced without signs of obstruction or invasion (1). Patients with hepatic adenomatosis usually have normal liver tests except for modest elevations of gamma glutamyl transpeptidase and alkaline phosphatase (1,5,22). The cause for elevated cholestatic enzymes is not known, but it may be secondary to localized intrahepatic cholestasis caused by obstruction of regional bile ducts. Histopathologic changes are similar in liver cell adenoma and adenomatosis. The tumors consist of fairly normal or enlarged hepatocytes without nuclear pleomorphism arranged in one to two cell thick cords. The adenoma cells may contain fat and glycogen. Numerous prominent venous outflow channels are seen, occasionally with closely related branching small arterioles (22). Biliary structures and portal triads are absent. Sinusoidal dilatation, peliosis, hemorrhage, and necrosis may be observed. The tumors are usually nonencapsulated (1,2,5,22). The prognosis and evolution of adenomatosis is generally uncertain. The main concerns of long-term follow-up are the potential for malignant transformation and hemorrhagic complications. There have been no reports of malignant transformation. Serum α-fetoprotein values are usually normal at the time of diagnosis and are of questionable value in long-term follow-up. A review by Neuberger et al. of seven patients with hepatic adenoma associated with oral contraceptive use and with malignant transformation showed no rise in serum α-fetoprotein levels in any patient (17). Surgical intervention is mainly reserved for the management of acute emergencies following hemorrhage. Although an open biopsy or surgical excision of an isolated adenoma is frequently performed to establish an initial diagnosis, surgical excision of all the tumors often is not possible, given the number and location of these lesions. Large adenomas (>10 cm in diameter) have been excised to reduce the risk of hemorrhage (23). Liver transplantation is also an option, but it seems unwarranted given the benign biologic nature of the adenomas. Percutaneous ethanol injections following contrast-enhanced ultrasound is an alternative therapy that needs to be explored. Although this treatment modality has never been used before for hepatic adenomatosis, it has been successful in inducing tumor necrosis in hepatocellular carcinoma (20). Tanaka et al. (24) have also used combination therapy, consisting of pretreatment with transcatheter arterial embolization and subsequent percutaneous ethanol injections, for solitary large primary hepatocellular carcinoma lesions. These options are being considered for our patient. A conservative approach to the management of hepatic adenomatosis seems to be the most reasonable option. This entails close monitoring of the clinical status and repeated radiological studies to assess any change in the size of the tumors. Rapid growth, hemorrhage, or encroachment on vital structures would justify surgical intervention, including orthotopic liver transplantation.FIG. 1.: Anterior view of a contrast enhanced CT scan of the liver showing multiple well-defined areas of low attenuation. The areas show ringlike peripheral enhancement with irregular central enhancement.FIG. 2.: A low-power view of one of the lesions showing sheets of hepatocytes with macrovesicular steatosis. Several thin-walled vessels are visible, but no portal tracts are present in the entire tissue. (H&E, approximate final magnification × 300)
No takes yet. Share an insight, caveat, or question.
Gokhale et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: